Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective

Berry D, Yao M, Barden JA, Balcar VJ, Hansen MA (1998) Alterations in the expression of P2X1 receptors in failing and non-diseased human atria. Electrophoresis 19:856–859

Berry D, Barden JA, Balcar VJ, Keogh A, dos Remedios CG (1999) Increase in expression of P2X1 receptors in the atria of patients suffering from dilated cardiomyopathy. Electrophoresis 20:2059–2064

Berry DA, Keogh A, dos Remedios CG (2001) Nuclear membrane proteins in failing human dilated cardiomyopathy. Proteomics 1:1507–1512

Boateng SY, Belin RJ, Geenen DL, Margulies KB, Martin JL et al (2007) Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein. Am J Physiol Heart Circ Physiol 292:H259–H269

Bos JM, Poley RN, Ny M, Tester DJ, Xu X et al (2006) Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 88:78–85

Bovill E, Westaby S, Crisp A, Jacobs S, Shaw T (2008) Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J Thorac Cardiovasc Surg 137:853–861. https://doi.org/10.1016/j.jtcvs.2008.09.006

Chahine MN, Mioulane M, Sikkel MB, O’Gara P, dos Remedios CG et al (2014) Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts. Cardiovasc Res 105:31–43. https://doi.org/10.1093/cvr/cvu218

Court NW, dos Remedios CG, Cordell J, Bogoyevitch MA (2002) Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 34:413–426

Crossman DJ, Shen X, Jüllig M, Munro M, Hou Y et al (2017) Increased collagen within the transverse tubules in human heart failure. Cardiovasc Res 113:879–891. https://doi.org/10.1093/cvr/cvx055

Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M et al (1999) Misspence mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med 341:1715–1724

Hou M, Malmsjö M, Möller S, Pantev E, Bergdahl A, Zhao XH, Sun XY, Hedner T, Edvinsson L, Erling D (1999) Increase in cardiac P2X1- and P2Xy2-receptor mRNA levels in congestive heart failure. Life Sci 65:1195–1206

Huang Z-P, Ding Y, Chen J, Wu G, Kataoka M, Wang D-Z et al (2016) Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy. Cardiovasc Res 112:543–554. https://doi.org/10.1093/cvr/cvw201

Iskratsch T, Lange S, Kho AL, dos Remedios CG, Ehler E (2010) Formin follows function: a muscle specific isoform of FHOD3 is regulated by CK2 phosphorylation and promotes myofibril maintenance. J Cell Biol 191:1159–1172

Lal S, Li A, dos Remedios C (2016) Limitations in translating animal studies to humans in cardiovascular disease. J Cardiovasc Transl Res 9:165–166. https://doi.org/10.1007/s12265-016-9676-2

Lange S, Gehmlich K, Lun AS, Blondelle J, Hooper C et al (2016) MLP and CARP are linked to chronic PKCa signalling in dilated cardiomyopathy. Nat Commun 7:12120. https://doi.org/10.1038/ncomms12120

Li A, dos Remedios CG (2015) Special issue on human heart failure. Biophys Rev 7:1–3

Li A, Ponten F, dos Remedios CG (2012) The interactome of Lim domain proteins: the contributions of LIM domain proteins to heart failure and heart development. Proteomics 12:203–225. https://doi.org/10.1002/pmic.201100492

Li A, Estigoy C, Raftery M, Cameron D, Odeberg J et al (2013) Heart research advances using database search engines, human protein atlas and the Sydney Heart Bank. Heart Lung Circ 22:819–826

Lin Z, Guo H, Cao Y, Zohrabian S, Zhou P et al (2016) Acetylation of VGLL4 regulates hippo-YAP regulates growth-YAP signaling and postnatal growth. Dev Cell 39:466–479. https://doi.org/10.1016/j.devcel.2016.09.005.

Lu B, Yu H, Zwartbol M, Ruifrok WP, van Gilst WH et al (2012) Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models. Physiol Genomics 44:443–454. https://doi.org/10.1152/physiolgenomics.00148.2011

Ng DCH, Court NW, dos Remedios CG, Bogoyevitch MA (2003) Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts. Cardiovasc Res 57:333–346

Pleuss M, Daeubler G, dos Remedios CG, Ehler E (2015) Adaptations of cytoarchitecture in human dilated cardiomyopathy. Biophys Rev 7:25–32

Polden J, McManus CA, dos Remedios C, Dunn MJ (2011) A 2-D gel reference map of the basic human heart proteome. Proteomics 11:3582–3586

Ralevic C (2015) P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease. Curr Med Chem 22:851–865

Robinson AA, Dunn MJ, McCormack A, dos Remedios CG, Rose ML (2010) Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol 49:370–379

Schreckenbach T, Henn W, Kress W, Roos A, Maschke M et al (2013) Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve 47:127–134. https://doi.org/10.1002/mus.23500

Walweel K, Gomez-Hurtado N, Oo YW, Beard NA, dos Remedios C et al (2017a) Calmodulin mutants linked to catecholaminergic polymorphic ventricular tachycardia fail to inhibit human RyR2 channels during adrenergic stress. J Am Coll Cardiol 70:115–117. https://doi.org/10.1016/j.jacc.2017.04.055

Walweel K, Molenaar P, Imtiaz MS, Denniss A, dos Remedios C et al (2017b) Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts. J Mol Cell Cardiol 104:263–271. https://doi.org/10.1085/jgp.201311157